Skip to main content
Signal8

Winter Charles M.

SEC insider (Form 3/4/5 filer). CIK 0001960264. Chief Technical Officer at Janux Therapeutics, Inc. (JANX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.

Companies Winter Charles M. has filed insider reports for

  • Janux Therapeutics, Inc. (JANX): Officer, Chief Technical Officer
Winter Charles M. profile photo

Winter Charles M.

CIK: 0001960264

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Janux Therapeutics, Inc. logo
JANX

Janux Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Janux Therapeutics, Inc. logo
    JANX

    Janux Therapeutics, Inc.

    Jan 2, 2026
    Sale
    Direct
    2.4K shares at avg. $13.73$33K
  • Janux Therapeutics, Inc. logo
    JANX

    Janux Therapeutics, Inc.

    Jan 2, 2026
    Award
    Direct
    28.6K shares-
  • Janux Therapeutics, Inc. logo
    JANX

    Janux Therapeutics, Inc.

    Jan 2, 2025
    Award
    Direct
    23K shares-

1-3 of 3